Blocknomi
Key Highlights TEM shares decline 1.66% following FDA authorization for xT CDx platform Stock momentum reverses after FDA greenlights tumor-only profiling capability Regulatory clearance expands Tempus AI’s oncology diagnostic portfolio…
Related articles
-
Strategy Didn’t Sell Bitcoin in May, According to Polymarket
CryptoPotato Published 04.06.2026 10:13
-
Charles Hoskinson slams lawsuit targeting dormant Bitcoin wallets
Crypto.News Published 28.05.2026 10:00
-
Why Bitcoin Is Falling Behind Record-Breaking Stocks
CryptoPotato Published 29.05.2026 18:03
-
Robinhood clears final regulatory approval for $180M WonderFi deal ahead of expected June 1 close
The Block Published 26.05.2026 10:06
-
Premu.xyz: The Decentralized Polymarket Alternative – User Curated Prediction Markets Anyone Can Launch
BlockchainReporter Published 26.05.2026 21:35
-
Satoshi-era bitcoin whale moves over $200 million in BTC to FalconX, Cumberland: Onchain Lens
The Block Published 25.05.2026 08:35
-
Quantus Report Warns of Quantum Gap in Crypto Security
BlockchainReporter Published 27.05.2026 13:00
-
Bitcoin braces for PCE inflation, GDP data and Iran deal update
Crypto.News Published 24.05.2026 14:12